Characteristic | Number |
---|---|
Total number | 105 |
Median age (range) | 63 (45–83) years |
Sex | |
Male/female | 78/27 (74.3%/25.7%) |
Neoplasm histotype | |
Squamous cell carcinoma | 46 (43.8%) |
Adenocarcinoma | 42 (40.0%) |
Others | 17 (16.2%) |
T stage | |
T1 | 22 (20.9%) |
T2 | 59 (56.2%) |
T3 | 19 (18.1%) |
T4 | 5 (4.8%) |
N stage | |
N0 | 43 (41.0%) |
N1 | 40 (38.1%) |
N2 | 22 (20.9%) |
Clinical stage | |
I | 45 (42.9%) |
II | 33 (21.4%) |
III (A and B) | 27 (25.7%) |
Grade | |
1–2 | 45 (42.8%) |
3 | 60 (57.2%) |
Postoperative radiotherapy | |
Yes | 25 (23.8%) |
No | 80 (76.2%) |
Postoperative chemotherapy | |
Yes | 31 (29.5%) |
No | 74 (70.5%) |